Beyond the Risk Assessment: Building a Stronger QRM Culture
Share
Subscribe
Quality risk management should be more than a compliance exercise or another spreadsheet to complete. The real opportunity is to make it risk-based.
They cover:
- Why the industry is still struggling to fully embrace ICH Q9(R1)
- The shift from reactive risk assessments to proactive risk-based decision-making
- Why leadership, knowledge management, and organizational culture are critical to effective QRM
- How the new ISPE QRM Guide was designed as a practical handbook and toolkit for practitioners
- Why defining the right risk question should come before choosing a risk assessment tool
- How organizations can determine the appropriate level of formality for different risk scenarios
- The growing role of QRM in product availability and supply chain resilience
- Why practitioners should look beyond FMEA and consider different or combined risk tools
- How QRM can become an integrated part of strategic decision-making rather than simply a compliance requirement
The key takeaway: the future of QRM is not about doing more risk assessments. It is about creating a risk mindset where managing uncertainty becomes part of everyday decision-making across the organization. When risk management is integrated with knowledge, strategy, and business objectives, organizations can move from reacting to problems to identifying and addressing them before they happen.
thinking part of how organizations operate, make decisions, and protect patients.
In this episode of Risk Revolution, Nuala Calnan welcomes Dr. Alice Redmond, Chief Risk and Quality Officer at CAI and a longtime leader in the quality risk management community. They explore the current state of QRM across the life sciences industry, the persistent challenges following ICH Q9(R1), and the development of the new ISPE Quality Risk Management Guide.